LOC100041441 can contain PI3K inhibitors like LY294002 and Wortmannin function by attenuating the PI3K/Akt signaling axis, a pathway commonly associated with cell growth and survival. Inhibition by these chemicals can reduce the phosphorylation and activation of downstream targets that LOC100041441 may regulate or interact with. MEK inhibitors such as U0126 and PD98059 specifically diminish the MEK/ERK pathway activation, leading to suppressed cellular proliferation and differentiation signals. This action can alter the cellular milieu and influence the activity of LOC100041441 within these signaling routes. JNK inhibitor SP600125 and p38 MAPK inhibitor SB203580 specifically target components of the MAPK signaling network that manages cellular responses to stress and inflammation. By inhibiting these kinases, the chemicals can impact the stress response and inflammatory pathways, potentially affecting LOC100041441's role within these processes. Src kinase inhibition through PP2 can modulate multiple downstream signaling cascades that include cell adhesion, growth, and differentiation, which can affect the functional engagement of LOC100041441.
Rapamycin targets mTOR, a central regulator of protein synthesis and cell growth, providing a means to suppress these pathways and potentially influence the role of LOC100041441 in such processes. Dasatinib and Imatinib are tyrosine kinase inhibitors that impede Bcr-Abl and Src family kinases, along with c-Kit and PDGFR, which are crucial in growth factor signaling. The inhibition of these kinases can affect various cellular signaling pathways, altering the activity and regulatory mechanisms in which LOC100041441 participates. Olaparib, through the inhibition of PARP, can modulate the DNA damage response, a complex signaling network that maintains genomic stability. The alteration of this pathway can impact the dynamics of LOC100041441 in relation to DNA repair processes. Bortezomib, a proteasome inhibitor, can lead to the accumulation of misfolded proteins and cellular stress, affecting the ubiquitin-proteasome system and influencing the stability and degradation processes of proteins including LOC100041441.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which can downregulate Akt signaling pathways that LOC100041441 is part of. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which can alter stress response pathways involving LOC100041441. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, which can affect stress response and inflammatory pathways associated with LOC100041441. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, which can regulate downstream pathways involving LOC100041441. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which can prevent activation of ERK, affecting signaling pathways that involve LOC100041441. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which can decrease Akt pathway activity, potentially influencing LOC100041441. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which can suppress protein synthesis pathways that LOC100041441 is part of. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Inhibits Bcr-Abl and Src kinases, which can affect growth factor signaling pathways involving LOC100041441. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Inhibits Bcr-Abl, c-Kit, and PDGFR, which can alter signaling pathways and affect LOC100041441 activity. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Inhibits PARP, altering DNA damage response pathways that LOC100041441 is associated with. | ||||||